SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-06-000178
Filing Date
2006-02-13
Accepted
2006-02-10 17:59:27
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 corgentech_sc13g.htm SC 13G/A 102539
  Complete submission text file 0000898432-06-000178.txt   104747
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 650 GATEWAY BOULEVARD -- SOUTH SAN FRANCISCO CA 94080 6506249600
CORGENTECH INC (Subject) CIK: 0001131517 (see all company filings)

IRS No.: 770503399 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-79795 | Film No.: 06600153
SIC: 2834 Pharmaceutical Preparations